These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6199705)

  • 21. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is serum beta 2 microglobulin a useful marker in patients with breast cancer?
    Mulder H; Euser R; Winckers P; Schop C
    Anticancer Res; 1985; 5(3):321-2. PubMed ID: 3893312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laboratory findings in tumor patients. II].
    Wolff J; Anger G
    Z Arztl Fortbild (Jena); 1980 May; 74(10):469-73. PubMed ID: 6158804
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum alpha fetoprotein in gynaecologic related malignancies.
    Ishiguro T; Yoshida Y; Tenzaki T; Ohsima M; Suzuki H
    Zentralbl Gynakol; 1980; 102(21):1209-12. PubMed ID: 6163266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum levels of 4 tumor-associated antigens in the evaluation of the spread of breast carcinoma].
    Stefanović L; Kamenjicki E; Selir Z; Miljković L; Sterio B; Semnic R; Sljapić N
    Med Pregl; 1984; 37(3-4):107-12. PubMed ID: 6208469
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumour markers in ovarian cancer.
    van Nagell JR
    Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum enzymes in ovarian carcinoma.
    Dobryszycka W; Warwas M; Gerber J; Ujec M
    Neoplasma; 1979; 26(6):737-43. PubMed ID: 44348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical markers in prostatic cancer.
    Schacht MJ; Garnett JE; Grayhack JT
    Urol Clin North Am; 1984 May; 11(2):253-67. PubMed ID: 6203205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total lactate dehydrogenase and its isozymes in serum from patients with primary carcinoma of the ovary.
    Kikuchi Y; Hisano A; Kuki E; Hirata J; Nagata I
    Gynecol Obstet Invest; 1991; 31(3):161-5. PubMed ID: 2071055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum alpha-hydroxybutyrate dehydrogenase in patients with ovarian carcinoma.
    Kikuchi Y; Momose E; Kizawa I; Kuki E; Kato K
    Acta Obstet Gynecol Scand; 1985; 64(7):553-6. PubMed ID: 4082930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multiparametric approach to tumor markers detectable in serum in patients with carcinoma of the ovary or uterine cervix.
    Sarjadi S; Daunter B; Mackay E; Magon H; Khoo SK
    Gynecol Oncol; 1980 Oct; 10(2):113-24. PubMed ID: 6161862
    [No Abstract]   [Full Text] [Related]  

  • 32. Placental alkaline phosphatase as a tumor marker in ovarian cancer.
    Vergote I; Onsrud M; Nustad K
    Obstet Gynecol; 1987 Feb; 69(2):228-32. PubMed ID: 3808507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and prognosis of mucinous tumors of the ovary.
    Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
    Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
    Ayhan A; Guven S; Guven ES; Kucukali T
    Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lactic dehydrogenase: a tumor marker for dysgerminoma.
    Schwartz PE; Morris JM
    Obstet Gynecol; 1988 Sep; 72(3 Pt 2):511-5. PubMed ID: 3405571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Markers of carcinoma of the ovary: serum cystine aminopeptidase and leucine aminopeptidase, reliable diagnostic parameters?].
    Belgeri R; Monfrini O; Gilardi EM; Motta T; Frateschi M; Ferrario I
    Ann Ostet Ginecol Med Perinat; 1984; 105(5):325-30. PubMed ID: 6534245
    [No Abstract]   [Full Text] [Related]  

  • 37. Carcinoma of the ovary and serum lactic dehydrogenase levels.
    Awais GM
    Surg Gynecol Obstet; 1978 Jun; 146(6):893-5. PubMed ID: 653563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
    Chen C; Chen LQ; Chen LD; Yang GL; Li Y
    Hepatogastroenterology; 2008; 55(84):991-7. PubMed ID: 18705314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical markers in gynaecological cancer.
    Farrell RJ
    Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.